Close
Achema middle east
swop processing & packaging

KCCI seeks leniency for pharma industry

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Lonza Widens Cell and Gene Therapy Suite with New Products

Lonza widens cell and gene therapy suite by way...

No New Drug Submissions by the FDA With Shutdown in Place

The Food and Drug Administration (FDA), which is already...

How to Tell if Your Loved One is Developing an Addiction

Watching a loved one change in ways you do...

The Future of Balding Treatments: What’s New in 2025

Are you balding or thinning out on top? It...

The Karachi Chamber of Commerce & Industry (KCCI) has expressed discontentment on alleged closure of pharmaceutical industry in the city in the wake of deaths in PIC Lahore due to drug reaction.

In a statement issued here Wednesday, KCCI President Mian Abrar Ahmad said that due to the closure of alleged industry since 1st February 2012, its exports are hampered besides leaving over 500 people particularly female staff unemployed. He urged the government to give fair chances to the owners of the alleged pharma company to clarify their position and allow them to carry internal audit and investigation.

Mian Abrar articulated that such incidents of drug reactions had happened in the developed countries which caused several deaths. Likewise tragedies happen, however, nowhere in the world such penal actions are taken to forcefully close down the industry. It is general practice worldwide to impose fines and penalties rather victimizing and forceful closure, he added

Latest stories

Related stories

Lonza Widens Cell and Gene Therapy Suite with New Products

Lonza widens cell and gene therapy suite by way...

No New Drug Submissions by the FDA With Shutdown in Place

The Food and Drug Administration (FDA), which is already...

How to Tell if Your Loved One is Developing an Addiction

Watching a loved one change in ways you do...

The Future of Balding Treatments: What’s New in 2025

Are you balding or thinning out on top? It...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »